Put an End To Persistent Coughing Chicago, IL, Nov. 18,

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Put an End To Persistent Coughing

Chicago, IL, Nov. 18, 2013 (GLOBE NEWSWIRE) -- Do the winter months have you stocking up on cough drops? As time-starved adults, we love to grab the nearest over-the-counter cough remedy and hope for the best. But is there a better way? After years of research, chronic cough and throat clearing expert, Brian Rotskoff, MD, offers a confident, "Yes." In fact, he's helped 90 percent of his patients overcome chronic cough.

http://www.globenewswire.com/newsroom/prs/?pkgid=17319

Here's what happens:  We assume our chronic cough is a leftover cold or some other untreatable winter illness, so we power through and try to suppress our cough symptoms. Before we know it, we've been coughing for weeks and our spouses and coworkers are fed up. Voila, chronic cough!

But as Chicago allergist Dr. Rotskoff explains, "Chronic cough is not a diagnosis, it's a symptom. Persistent coughing that lasts more than a month is caused by some other condition, commonly multiple conditions. Very often that's why coughs last so long; they're misdiagnosed or singularly diagnosed and therefore only partially treated."

Can't stop coughing, you say?

The most common reason for a pestering cough is post-nasal drip. During a cold or sinus infection, post-nasal drainage is like a leaky faucet in the back of your throat. That constant irritation causes temporary inflammation and triggers coughing and throat clearing. But if you're more than a couple weeks past a cold and your cough is still going strong, chances are there's more to it.

"The first things I look for are asthma and acid reflux. Both are very likely, but often unsuspected, cough culprits," explained Dr. Rotskoff, an expert in the complexities of chronic cough. A large percentage of his Clarity Allergy Center patients suffer from compounding conditions; to treat only one would be a futile attempt at cough control.

An untreated cough can become a rather painful cycle as the repeated act of coughing continues to irritate airways. Without giving that tissue a chance to heal, patients can develop a chronic cough from nerve damage to the voice box (larynx).

According to Dr. Rotskoff, a lot can be learned from a chest x-ray. "Patients can save themselves months of suffering and medication-hopping," he said. If you've experience a chronic cough for one month or longer, schedule a thorough cough analysis with Chicago's Brian Rotskoff, MD. You - and those around you - will be glad you did.

T: 773-877-3500 North Chicago Office 4801 W. Peterson Avenue, Suite 306 Chicago, IL 60646 Chicago Office 3000 N. Halsted St, Suite 611 Chicago, IL 60657 Arlington Heights Office 125 South Wilke Road, Suite 100 Arlington Heights, IL 60005 http://www.clarityallergycenter.com/contact/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Antheia Secures $80M for Critical Medicine Onshoring

Updated Category News Views 26

Antheia's Bold Move to Onshore Medicine Production Folks, when it comes to pharmaceuticals, it's about time someone started serious about keeping things closer to home. Antheia just landed a huge $80 million conditional commitment from the U.S. Department of War's Office of Strategic Capital. The fine print? This isn't just about building business—it's a play to secure...

Continue Reading
Lundbeck's Board Leadership Transitions into New Era

Updated Category News Views 15

A Fresh Chapter for Lundbeck's Board Leadership Lundbeck is sparking some fresh boardroom energy, and it's not just business as usual. Dorothea Wenzel, who's been steering the ship, is stepping down come 2027—AGM in sight. Now, in swings Lars Fruergaard Jørgensen, ready to grab the wheel. Yeah, we've got some seasoned pharma muscles flexing here. The Before and After:...

Continue Reading
UEG's New Advisory Board: Elevating Patient Voices

Updated Category News Views 31

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

Continue Reading
Tomorrowland's Shanghai Return: An Electri-Lifesaver

Updated Category News Views 31

You know, every now and then, it's worth stepping out of the stock frenzy and diving into something as electrifying and far from the trading floor as Tomorrowland's latest Shanghai rendezvous. This ain't just any festival; it's the kind of hype that packs a punch—and frankly, it's a wild ride seeing such a spectacle set up shop in China, and sell out to boot. Partnering...

Continue Reading
Faith and Resilience in China: The Legacy of the Long March

Updated Category News Views 30

History's got chapters that stick with you, and the Long March is one of those stories that shake you to your core. It all started one October evening in 1934, when more than 86,000 soldiers from the Red Army found themselves on the banks of the Yudu River. It was a scene straight out of a novel: 800-odd boats held together with coffin boards and timber beams, all set to...

Continue Reading
ASTS Faces a Legal Countdown – Investors Take Note

Updated Category News Views 25

AST SpaceMobile's Legal Tangle AST SpaceMobile, Inc. (NASDAQ:ASTS) finds itself neck-deep in legal quagmire, with a class action lawsuit looming large. Investors who snapped up ASTS securities between March 4, 2025, and July 15, 2026, have until November 13, 2026, to reckon their grievances before the courts. This is no joke, folks. If you've lost dough because of shaky...

Continue Reading
AEVEX Faces 48-Hour Deadline for Investor Class Action

Updated Category News Views 23

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Breast Suite Transforming Cancer Detection and Care

Updated Category News Views 118

Introducing the AI-Driven DeepHealth Breast Suite DeepHealth has recently launched its Breast Suite, a revolutionary set of AI-powered applications that significantly boosts the effectiveness of breast cancer detection and patient care. This suite is part of a broader initiative to improve health informatics and operational efficiency, showcasing DeepHealth's commitment...

Continue Reading
AVATR Unveils Innovative Luxury Electric Vehicle in Munich

Updated Category News Views 193

AVATR Unveils Innovative Luxury Electric Vehicle in Munich At the recent "Brilliant New Horizon AVATR Brand Day" event, the President of AVATR Technology, Mr. Chen Zhuo, shared insights about the brand's identity. He explained that AVATR transcends the typical electric vehicle company image by embracing high-end sophistication, intelligence, and design. Emotional...

Continue Reading
Security Federal Corporation Expands Stock Repurchase Program

Updated Category News Views 128

Security Federal Corporation Unveils New Stock Repurchase Program Security Federal Corporation (the “Company”) (OTCBB: SFDL), which serves as the holding company for Security Federal Bank (the “Bank”), has recently announced an increase in the number of shares it is authorized to repurchase under its existing stock repurchase program. This updated initiative...

Continue Reading
Experience 'Hot Fellas' Bakery: Immersive NYC Event Awaits

Updated Category News Views 379

Unveiling the Hot Fellas Bakery Pop-Up Experience in NYC The beloved storyline of the Max Original series "And Just Like That…" springs to life with an exciting two-day immersive pop-up event. Fans will have the unique opportunity to step into Anthony Marentino's famous 'Hot Fellas' Bakery, inviting them to participate in a fun and delicious experience. Details of the...

Continue Reading
EyePoint Pharmaceuticals Pursues Major Stock Offering for Growth

Updated Category News Views 228

EyePoint Pharmaceuticals Pursues Major Stock Offering EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leader in developing innovative therapies for patients suffering from serious retinal diseases, has taken a significant step toward advancing its initiatives by announcing a proposed underwritten public offering. The company is set to offer $150 million of its common...

Continue Reading